These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD. Nevalainen PI, Lahtela JT, Mustonen J, Taskinen MR, Pasternack A. Perit Dial Int; 1999; 19(2):148-53. PubMed ID: 10357186 [Abstract] [Full Text] [Related]
3. Subcutaneous versus intraperitoneal insulin for patients with diabetes mellitus on continuous ambulatory peritoneal dialysis: meta-analysis of non-randomized clinical trials. Almalki MH, Altuwaijri MA, Almehthel MS, Sirrs SM, Singh RS. Clin Invest Med; 2012 Jun 01; 35(3):E132-43. PubMed ID: 22673316 [Abstract] [Full Text] [Related]
11. [Continuous ambulatory peritoneal dialysis treatment and blood glucose control in diabetics with end-stage diabetic nephropathy]. Li GW, Liu J, Chen L. Zhonghua Nei Ke Za Zhi; 1989 Jun 01; 28(6):360-3, 382. PubMed ID: 2684575 [Abstract] [Full Text] [Related]
12. Administration of insulin by continuous ambulatory peritoneal dialysis. Chan E, Montgomery PA. Pharmacotherapy; 1993 Jun 01; 13(5):455-60. PubMed ID: 8247911 [Abstract] [Full Text] [Related]
13. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment. Scarpioni L, Ballocchi S, Scarpioni R, Cristinelli L. Perit Dial Int; 1996 Jun 01; 16 Suppl 1():S275-8. PubMed ID: 8728206 [No Abstract] [Full Text] [Related]
14. Decreasing insulin requirements in CAPD patients given intraperitoneal insulin. Grefberg N, Danielson BG, Berne C. J Diabet Complications; 1987 Jun 01; 1(1):16-9. PubMed ID: 2968990 [Abstract] [Full Text] [Related]
18. Continuous ambulatory peritoneal dialysis in the treatment of end-stage diabetic nephropathy. Grefberg N, Danielson BG, Nilsson P. Acta Med Scand; 1984 Jun 01; 215(5):427-34. PubMed ID: 6377827 [Abstract] [Full Text] [Related]